Your browser doesn't support javascript.
loading
Expanding access to HIV services during the COVID-19 pandemic-Nigeria, 2020.
Boyd, Andrew T; Jahun, Ibrahim; Dirlikov, Emilio; Greby, Stacie; Odafe, Solomon; Abdulkadir, Alhassan; Odeyemi, Olugbenga; Dalhatu, Ibrahim; Ogbanufe, Obinna; Abutu, Andrew; Asaolu, Olugbenga; Bamidele, Moyosola; Onyenuobi, Chibuzor; Efuntoye, Timothy; Fagbamigbe, Johnson O; Ene, Uzoma; Fagbemi, Ayodele; Tingir, Nguhemen; Meribe, Chidozie; Ayo, Adeola; Bassey, Orji; Nnadozie, Obinna; Boyd, Mary Adetinuke; Onotu, Dennis; Gwamna, Jerry; Okoye, McPaul; Abrams, William; Alagi, Matthias; Oladipo, Ademola; Williams-Sherlock, Michelle; Bachanas, Pamela; Chun, Helen; Carpenter, Deborah; Miller, David A; Ijeoma, Ugonna; Nwaohiri, Anuli; Dakum, Patrick; Mensah, Charles O; Aliyu, Ahmad; Oyeledun, Bolanle; Okonkwo, Prosper; Oko, John O; Ikpeazu, Akudo; Aliyu, Gambo; Ellerbrock, Tedd; Swaminathan, Mahesh.
Afiliação
  • Boyd AT; Centers for Disease Control and Prevention, Division of Global HIV and TB, Center for Global Health, 1600 Clifton Road NE, Atlanta, GA, 30329, USA. ipo2@cdc.gov.
  • Jahun I; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Dirlikov E; Centers for Disease Control and Prevention, Division of Global HIV and TB, Center for Global Health, 1600 Clifton Road NE, Atlanta, GA, 30329, USA.
  • Greby S; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Odafe S; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Abdulkadir A; Maryland Global Initiatives Corporation, University of Maryland School of Medicine Nigeria Program, Abuja, Federal Capital Territory, Nigeria.
  • Odeyemi O; Maryland Global Initiatives Corporation, University of Maryland School of Medicine Nigeria Program, Abuja, Federal Capital Territory, Nigeria.
  • Dalhatu I; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Ogbanufe O; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Abutu A; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Asaolu O; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Bamidele M; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Onyenuobi C; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Efuntoye T; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Fagbamigbe JO; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Ene U; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Fagbemi A; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Tingir N; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Meribe C; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Ayo A; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Bassey O; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Nnadozie O; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Boyd MA; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Onotu D; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Gwamna J; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Okoye M; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Abrams W; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Alagi M; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Oladipo A; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
  • Williams-Sherlock M; Centers for Disease Control and Prevention, Division of Global HIV and TB, Center for Global Health, 1600 Clifton Road NE, Atlanta, GA, 30329, USA.
  • Bachanas P; Centers for Disease Control and Prevention, Division of Global HIV and TB, Center for Global Health, 1600 Clifton Road NE, Atlanta, GA, 30329, USA.
  • Chun H; Centers for Disease Control and Prevention, Division of Global HIV and TB, Center for Global Health, 1600 Clifton Road NE, Atlanta, GA, 30329, USA.
  • Carpenter D; Centers for Disease Control and Prevention, Division of Global HIV and TB, Center for Global Health, 1600 Clifton Road NE, Atlanta, GA, 30329, USA.
  • Miller DA; Centers for Disease Control and Prevention, Division of Global HIV and TB, Center for Global Health, 1600 Clifton Road NE, Atlanta, GA, 30329, USA.
  • Ijeoma U; Centers for Disease Control and Prevention, Division of Global HIV and TB, Center for Global Health, 1600 Clifton Road NE, Atlanta, GA, 30329, USA.
  • Nwaohiri A; Centers for Disease Control and Prevention, Division of Global HIV and TB, Center for Global Health, 1600 Clifton Road NE, Atlanta, GA, 30329, USA.
  • Dakum P; Institute of Human Virology (IHVN), Abuja, Federal Capital Territory, Nigeria.
  • Mensah CO; Institute of Human Virology (IHVN), Abuja, Federal Capital Territory, Nigeria.
  • Aliyu A; Institute of Human Virology (IHVN), Abuja, Federal Capital Territory, Nigeria.
  • Oyeledun B; Center for Integrated Health Program (CIHP), Abuja, Federal Capital Territory, Nigeria.
  • Okonkwo P; AIDS Prevention Initiative Nigeria (APIN), Abuja, Federal Capital Territory, Nigeria.
  • Oko JO; Catholic Caritas Foundation Nigeria (CCFN), Abuja, Federal Capital Territory, Nigeria.
  • Ikpeazu A; Federal Ministry of Health, Abuja, Nigeria.
  • Aliyu G; National Agency for the Control of AIDS, Abuja, Federal Capital Territory, Nigeria.
  • Ellerbrock T; Centers for Disease Control and Prevention, Division of Global HIV and TB, Center for Global Health, 1600 Clifton Road NE, Atlanta, GA, 30329, USA.
  • Swaminathan M; Centers for Disease Control and Prevention Nigeria, Division of Global HIV and TB, Center for Global Health, Abuja, Federal Capital Territory, Nigeria.
AIDS Res Ther ; 18(1): 62, 2021 09 19.
Article em En | MEDLINE | ID: mdl-34538268

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Africa Idioma: En Revista: AIDS Res Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Africa Idioma: En Revista: AIDS Res Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos